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Abstract
Anorexia nervosa (AN) and body dysmorphic disorder (BDD) are potentially life-threatening
conditions whose partially overlapping phenomenology—distorted perception of appear-
ance, obsessions/compulsions, and limited insight—can make diagnostic distinction difficult
in some cases. Accurate diagnosis is crucial, as the effective treatments for AN and BDD dif-
fer. To improve diagnostic accuracy and clarify the contributions of each of the multiple
underlying factors, we developed a two-stage machine learning model that uses multimodal,
neurobiology-based, and symptom-based quantitative data as features: task-based func-
tional magnetic resonance imaging data using body visual stimuli, graph theory metrics of
white matter connectivity from diffusor tensor imaging, and anxiety, depression, and insight
psychometric scores. In a sample of unmedicated adults with BDD (n = 29), unmedicated
adults with weight-restored AN (n = 24), and healthy controls (n = 31), the resulting model
labeled individuals with an accuracy of 76%, significantly better than the chance accuracy of
35% (p^ < 10  4). In the multivariate model, reduced white matter global efficiency and better
insight were associated more with AN than with BDD. These results improve our under-
standing of the relative contributions of the neurobiological characteristics and symptoms of
these disorders. Moreover, this approach has the potential to aid clinicians in diagnosis,
thereby leading to more tailored therapy.
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Introduction
Anorexia nervosa (AN) and body dysmorphic disorder (BDD) are psychiatric disorders that
share several phenomenological characteristics such as distorted perception of appearance [1],
obsessive and compulsive symptoms [2], and poor insight [3,4]. BDD is characterized princi-
pally by an individual’s preoccupation with a perceived defect in their appearance [1]. Preva-
lence in the general population is estimated between 0.7% [5,6] and 2.9% [7,8]. AN is
characterized by restriction of energy intake, fear of gaining weight or becoming fat, distur-
bance in the individual’s perception of body weight, and significantly low BMI [1]. The preva-
lence is estimated to be 0.9% and 0.3% in females and males, respectively [9].
Both disorders are very serious conditions that confer an elevated risk of mortality. Of all
psychiatric disorders, AN has the highest risk of mortality: 0.6% per year [10,11]. Medical mor-
bidity and mortality related to the starvation state are major risks in affected persons [12]. Dur-
ing the lifetime of an individual with a BDD diagnosis, 24–28% will attempt suicide [13]; the
suicide-related mortality rate in individuals with BDD is roughly 0.3% per year [14]. The
alarmingly frequent mortalities and severe risks associated with AN and BDD underscore that
it is imperative to recognize these disorders and to intervene with treatment to minimize poor
outcomes.
The selection of an effective treatment for AN or BDD is aided by proper diagnosis. Cogni-
tive behavioral therapy (CBT) can be effective in BDD [15], but its usefulness in AN is minimal
[16]. BDD can respond to treatment with selective serotonin reuptake inhibitors (SSRIs), but
evidence for this in AN is lacking [17,18]. Family-based psychotherapy in adolescents with AN
has been shown to be effective [19].
Clinically, it can be difficult in some cases to distinguish between AN and BDD. Similarities
in symptom characteristics are such that some researchers have raised the question of whether
one disorder should be considered a subtype of the other, or at least have noted that they share
pathological features [20,21]. For example, 30% of individuals with BDD have significant
weight-related appearance concerns (e.g., concern about their cheeks being too fat), even if
they do not have a comorbid eating disorder [22]. Consequently, individuals with BDD may
restrict calorie intake and engage in appearance-related compulsive behaviors. In this example,
Diagnostic Statistical Manual (DSM-5 or DSM-IV) criteria would categorize the person as
having AN or AN plus BDD if the body weight was less than 85% of that expected, and BDD
alone if 85% or above. However, the behavioral manifestations and subjective experience for
the patient may be otherwise identical.
In fact, individuals frequently meet criteria for both AN and BDD [23,24]. Of those with
AN, 25–39% are diagnosed with lifetime BDD; 32% of those with BDD will have a lifetime eat-
ing disorder [23–25]. In studies that directly compared individuals with AN to those with
BDD, the two groups shared lower body satisfaction, lower appearance evaluation, lower atti-
tudes toward one’s self, more body areas of dissatisfaction, and greater preoccupation with
being overweight, compared with healthy controls [26–28]. In terms of clinically distinguish-
ing features, aside from the low body weight criteria in AN, the sex distribution is notably
more skewed toward females in AN (90% female), whereas BDD has a more equal prevalence
across sexes [7,29]. While insight tends to be poor in both conditions, it is worse on average in
BDD [4]. With these data in mind, we believe that it would be advantageous to have additional
quantitative means of distinguishing between these conditions.
Neuroimaging has provided several features that may help distinguish between individuals
with AN, those with BDD, and healthy controls. Recent research suggests that distorted per-
ceptions of appearance may be linked to abnormalities in the visual system [30–32]. A com-
bined analysis of data from task-based functional magnetic resonance imaging (fMRI) and
Differentiating anorexia nervosa and body dysmorphic disorder using neuroimaging and psychometric markers
PLOS ONE | https://doi.org/10.1371/journal.pone.0213974 May 6, 2019 2 / 16
Availability policy. For data sets involving
personally identifiable information or other
sensitive data, data sharing is contingent on the
data being handled appropriately by the data
requester and in accordance with all applicable
local requirements. The authors will keep the data
archived on their UCLA server for 5 years with a
backup on a hard drive. After 5 years it will either
remain on the server with a hard drive backup, or
will be archived to a hard drive with a second hard
drive backup, in the laboratory of Dr. Feusner.
Jamie Feusner jfeusner@mednet.ucla.edu) and
Teena Moody (tmoody@g.ucla.edu) and Don
Vaughn (davaughn@ucla.edu) can be contacted for
requests. Requests should briefly answer the
following questions: (1) Please describe the
proposed analyses. Include the research question
and hypotheses, variables you intend to analyze, a
brief analysis plan, methods, and references. (2)
Please briefly describe what resources you can
have available for the project (e.g., researcher time,
resources for processing and analyzing data). (3)
Please verify that you will only use data for your
project and will not distribute to others.
Funding: This work was supported by NIMH
grants (R01MH093535 and R01MH105662) to
JDF, a Postdoctoral Fellowship to DAV from the
UCLA Collaboratory directed by Matteo Pellegrini.
Support for WTK was provided by NIH
T32GM08042 and the Eisenhower Medical Center
Department of Internal Medicine. The authors
declare no conflict of interest regarding the
publication of this article.
Competing interests: The authors have declared
that no competing interests exist.
EEG showed that, relative to healthy controls, individuals with AN and those with BDD exhib-
ited hypoactivity in both early secondary visual regions and the dorsal stream when viewing
low-spatial frequency face and house stimuli [33]. An event-related potential (ERP) analysis of
the same EEG data likewise revealed that the amplitude of P100 responses was smaller in indi-
viduals with AN than in those with BDD and in healthy controls, whereas N170 latencies were
longer and N170 amplitudes were smaller in AN and BDD compared with healthy controls [34].
Diffusion tensor imaging (DTI) additionally has demonstrated that brain white matter con-
nectivity patterns differ in individuals with BDD and healthy controls [35], and between indi-
viduals with AN and healthy controls [36]. Connectivity pattern abnormalities in white matter
networks have been found within the visual system of individuals with BDD [3,37]. Among
the few studies that have compared AN and BDD directly, correlations were present between
psychometric insight and ERP amplitude in BDD but not in AN [34]. Insight was correlated
with the network measure path length in white matter in AN but not in BDD [3]. Despite
these known neurological differences, a differential diagnosis currently is made using criteria
based principally on weight, observed behaviors, and reported symptoms.
It is important also to distinguish psychiatrically ill individuals from healthy controls. This
is an issue particularly in adolescents, the age group most likely to develop AN and BDD. The
role of clinicians is to identify patients who would benefit from treatment while avoiding a
pathologic diagnosis for normal adolescents. Mislabeling developmentally-normal, self-con-
scious behavior (e.g., overvaluing appearance, mirror-checking) as a disorder can have detri-
mental effects on an individual’s perceived identity (Rosenhan, 1973). On the other hand,
mislabeling a disorder as normal development could normalize the pathologic behaviors and
experiences of AN and BDD (e.g., purging, compulsive behaviors, significant interference in
functioning, emotional distress). BDD often goes undetected in adolescents [38], yet the sui-
cide attempt rate is possibly higher than in adults (21–44%) [39].
With this background in mind, our current study had two goals: 1) to understand mecha-
nistically the multivariate differences in neurobiology and psychometric scales that map to the
diagnoses, and 2) to aid clinicians by developing an enhanced and more objective means of
distinguishing between AN, BDD, and healthy controls. Both of these goals were achieved by
combining multimodal neuroimaging and psychometric data into a multivariate logistic
regression model. The feature weights of the multivariate model address the first goal by pro-
viding an evidence-based magnitude, direction, and significance as to how each modality
relates to a particular diagnosis. The model’s probabilistic outputs address the second goal by
providing diagnostic predictions. Although many studies of psychiatric populations collect
more than one modality of neurobiological data and multiple psychometric scales, few have
combined these in fully integrated models to enhance the accuracy of predictive classification
(or for other purposes).
Materials and methods
Participants
Our study included data from 84 participants (age 22 +/- 5 years, 88% female): 24 diagnosed
with weight-restored AN, 29 diagnosed with BDD, and 31 healthy controls. All participants
were unmedicated. The University of California, Los Angeles (UCLA) Institutional Review
Board approved the protocol, and all participants provided written informed consent. Capacity
to provide informed consent was determined by the study physician (Dr. Feusner). For minors
who participated we obtained signed parental permission and youth assent.
For semantic ease, we defined AN/BDD to be all of the participants with either AN or BDD;
AN/BDD does not indicate that the participants were comorbid with both disorders, as
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participants with both AN and BDD were excluded. Participants were of equivalent age and
gender (Table 1).
We excluded participants who met any of the following criteria: (1) medical disorders
affecting cerebral metabolism (e.g., diabetes mellitus or hyperthyroidism); (2) pregnancy; (3)
neurological disorders; (4) concurrent Axis I disorders other than dysthymia, major depressive
disorder, or generalized anxiety disorder; (5) score>44 (very severe) on the Montgomery-
Åsberg Depression Rating Scale (MADRS) [40] and/or major depressive disorder with psy-
chotic features; (6) an assessment of imminent suicidality (by Dr. Feusner); (7) current or past
diagnosis of AN (in the BDD group) or a current or past diagnosis of BDD (in the AN group);
and (8) current treatment with CBT. Participants were required to be free from psychoactive
medications for at least 8 weeks prior to entering the study. To avoid the confounds of acute
starvation on brain structure and function, all participants with AN had to be weight-restored
during data collection (as defined by BMI� 18.5) despite having previously met full DSM-IV
criteria for AN. BDD participants had to score� 20 on the BDD version of the Yale-Brown
Obsessive Compulsive Scale (BDD-YBOCS) [41].
Psychometrics
To establish diagnoses, all participants were administered the Mini International Neuropsychi-
atric Interview (MINI) [42] and the BDD Diagnostic Module [43], modeled after the DSM-IV.
Symptom severity was quantified in AN with modified versions of the Yale-Brown-Cornell Eat-
ing Disorder Scale (YBC-EDS) [44] and the Eating Disorder Evaluation (EDE) Edition 16.0D
[45], and in BDD with the BDD-YBOCS [41]. Participants with AN and those with BDD, were
administered the Brown Assessment of Beliefs Scale (BABS) [46], the Hamilton Anxiety Rating
Scale (HAM-A) [47], and the Montgomery-Asberg Depression Scale (MADRS) [40].
Overview and rationale of feature selection
The principal goal of the study was to create a classification model to help distinguish AN/BDD
from healthy controls, and AN from BDD. To make use of a range of neurobiological and psy-
chometric data, we chose structural (DTI) and functional (fMRI) data (acquired in all groups),
psychometric ratings measuring anxiety and depression (acquired in all groups), and insight
(acquired in AN and BDD). From the DTI data, we chose to use the graph theory metric of nor-
malized path length (NPL) because 1) this global network connectivity measure provides a single
summarized metric of white matter network connectivity for each participant, and 2) our previ-
ous univariate analysis suggested differing patterns in AN and BDD [3]. We chose to include
fMRI task data from brain responses to both low and high spatial frequency bodies and faces. We
Table 1. Demographics.
AN BDD CTL Test statistic p
Age (yrs) 21 ± 5 23 ± 5 21 ± 5 F = 2.2, df = 2 0.12
Female 23/24 (96%) 26/29 (90%) 25/31 (81%) x2 = 3.1, df = 2 0.21
BMI 20 ± 2 22 ± 3 22 ± 3 F = 4.1, df = 2 0.02
Illness duration (months) 72 ± 63 118 ± 70 N/A t = 2.6, df = 51 0.03
Lowest lifetime BMI 16 ± 2 N/A N/A N/A N/A
Number of participants 24 29 31 N/A N/A
Healthy controls (denoted as CTL in this table), participants with AN, and participants with BDD were matched across age, gender, and body mass index (BMI).
Participant age and the proportion of females were not significantly different across groups; BMI and illness duration differed significantly between groups. Errors are
standard deviation.
https://doi.org/10.1371/journal.pone.0213974.t001
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hypothesized that bodies and faces (rather than the third stimuli class, houses) would best distin-
guish both controls from AN/BDD and distinguish AN from BDD, because bodies were likely to
be more salient for people with AN and faces for those with BDD [48].
fMRI data
We collected fMRI data as participants engaged in simple tasks of matching photographs of
others’ bodies and of others’ faces [49]. Each run contained blocks of images with low-only,
normal, or high-only spatial-frequency content, and a control task of matching shapes. Previ-
ous analyses suggested that the stimuli types that showed the least overlap between participants
with AN/BDD and controls were low and high spatial-frequency images; thus, we used
responses to high and low spatial-frequency but not normal spatial-frequency images from the
bodies and faces data as features in our model. In the interest of deriving a signal metric per
network, we executed a network coherence analysis of the functional data. Based on previous
results, we hypothesized that the most informative coherence values would come from three
networks of interest: primary visual, higher order visual, and salience networks [50]. For fur-
ther detail, see supplementary material.
DTI data
The neuroimaging data included DTI in the form of 64 gradient direction diffusion-weighted
images with b = 1000 s/mm2 and one minimally diffusion-weighted scan (the B0 image).
Graph theory metric data were obtained from a processing pipeline previously described [3].
Briefly, we derived 87 cortical and subcortical structures using Freesurfer (Martinos Center for
Biomedical Imaging, USA) from each participant’s T1-weighted scan data, and we performed
continuous fiber tracking from the diffusion-weighted data using DTIStudio software (http://
www.mristudio.org). Combining the parcellation and fiber tractography results yielded an 87
x 87 connectivity matrix of tractography relationships between regions. For each participant’s
data, we calculated the shortest path length between each pair of nodes and then averaged this
path length over all nodes to determine the characteristic path length (CPL). We calculated the
normalized path length (NPL) as the ratio of observed CPL to the CPL of an identically sized
but randomly connected network [51].
Handling the missing data
As is a challenge with many multimodal datasets, we had missing data for some participants across
psychometric and neuroimaging modalities. We addressed this problem using multiple imputa-
tion [52]. Due to a modified initial study design, the first eight participants with AN did not com-
plete the BABS. None of the control participants completed the BABS because they, by definition,
had no disorder for which they could provide insight. We did not use functional data from 27 of
the participants because of their excessive head movement. Of our 84 participants, we had data for
100% of HAM-A/MADRS, 85% (45/53) of the BABS, 100% of DTI, and 68% (57/84) of fMRI.
Additionally, we also performed a complete case analysis using the 57 participants for
whom we had no missing data (17 AN, 19 BDD, 21 control). The complete case results—in
terms of model performance, feature significance, and feature magnitude—were not dissimilar
from the imputation model and thus are not discussed further.
Diagnostic statistical modeling
We predicted the diagnoses using a two-step multiple-imputation logistic regression model;
we first predicted whether a participant was a healthy control or had AN/BDD, and for the
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latter group, we predicted the disorder (AN or BDD). As features, we used coherence values
from fMRI data in primary visual, higher order visual, and salience networks using body and
face high- and low spatial-frequency visual stimuli; white matter NPL from DTI data; and anx-
iety, depression, and insight psychometric scores. We trained these models using cyclical
leave-one-out cross-validation and assessed their statistical significance via permutation test-
ing, which yielded an empirical, two-tailed p-value indicated by p^. All confidence intervals
(CI) are 95% standard error of the mean (SEM), unless otherwise stated.
Results
Dataset information
There were significant univariate differences between participants with AN, participants with
BDD, and healthy controls. Participants with BDD had significantly higher BABS scores
(4.6 ± 1.5) than participants with AN (t = 3.1, df = 43, p = 0.004) (Fig 1A). Participants with
AN, those with BDD, and healthy controls had unequal mean NPL (F = 4.8, df = 2, p = 0.01,
Fig 1B). This difference in central tendency was driven by the AN group (μAN-μBDD =
0.11 ± 0.03, t = 3.3, df = 51, p = 0.002), specifically a bimodal distribution of AN participants
with NPLs that were either similar or much longer than the BDD and control groups. Note
that this bimodality was not explained by large fluctuations in the denominator (CPL of an
equivalent random network) (Fig 1C). Healthy controls scored significantly lower than partici-
pants with AN/BDD on both the HAM-A (μA/B-μC = 7.8 ± 1.2, t = 6.3, df = 82, p<10−4, Fig
1D) and MADRS (μA/B-μC = 13.5 ± 1.6, t = 8.2, df = 82, p<10−4, Fig 1E). We observed a high
Pearson correlation between the HAM-A and MADRS scores of all three participant groups
(r = 0.85 ± 0.05). Thus, we collapsed both scales into a single combined metric, MH, by extract-
ing the first principal component, which explained 93% of the variance in the data (Fig 1F).
Because of excessive head movement, we had to exclude fMRI data from 29% (7/24) of par-
ticipants diagnosed with AN, 34% (10/29) of participants diagnosed with BDD, and 32% (10/
31) of controls. There was no significant difference in the proportion with missing data across
the three groups (Chi-squared, 0.17, df = 3, p = 0.92).
Given that only 68% of coherence values were available, we conducted a preliminary analy-
sis to evaluate whether imputed coherence explained a significant amount of the residual vari-
ance in the models. We used a regularized logistic regression model to evaluate the marginal
effect of including a combination of high and low spatial frequency stimuli of faces and bodies
for each of the three networks. The regularized model did not significantly explain more varia-
tion in the data, when considering the number of variables added (deviance difference 12.8,
df = 12, p = 0.3). Additionally, the overall accuracy of this overall model decreased with this
additional information, likely due to overfitting.
This suggests that the variation accounted for by coherence was explained by other variables
in the limited model, and thus, the inclusion of coherence did not improve our prediction of
the outcome. Given this result, all subsequent analyses excluded coherence as a feature.
Distinguishing healthy controls from AN/BDD
When distinguishing healthy controls from participants with AN or BDD, the first step predic-
tive model had a leave-one-out accuracy of 89% (75/84, permutation mean 41%, p^ < 0:01), a
positive predictive value (PPV) of 92% (48/52, permutation mean 53%, p^ < 0:01), a negative
predictive value (NPV) of 84% (27/32, permutation mean 33%, p^ < 0:01), and an area under
the receiver operator characteristic (AUC-ROC) of 93% (Fig 2A). The overall deviance differ-
ence was 66.2 (df = 2, p<10−4), and this was driven by a significant association of lower MH
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with healthy controls (estimate 11.82 per PCA-unit, SE 3.00, p<10−4, Fig 2B). NPL was not
associated significantly with either group (estimate -2.5 per unit, SE 2.5, p^ = 0.31).
AN vs BDD prediction
The second step predictive model—designed to distinguish participants with AN from those
with BDD—had a leave-one-out accuracy of 74% (39/53, permutation mean 40%, p^ < 0:001),
an AN predictive value of 78% (14/18, permutation mean 40%, p^ < 0:01), a BDD predictive
value of 71% (25/35, permutation mean 41%, p^ < 0:001), and an AUC-ROC of 67% (Fig 2C).
The overall difference in deviance was 10.0 (df 3, p^ = 0.006) with a positive association of
Fig 1. Dataset information. (A) Participants with BDD had significantly different BABS scores than those with AN (p = 0.004). In this and all
remaining panels, the horizontal line is the mean, box is the SEM 95% CI, black lines demarcate one standard deviation, and dots reflect individual
participants. (B) NPL differed significantly between AN and BDD groups (p = 0.002). (C) The NPL comprised the observed CPL and the CPL of an
equivalently-sized random network. This plot demonstrates that the denominator of NPL—the CPL of an equivalent random network—does not
show large fluctuations that would explain the bimodal distribution in AN as presented in panel B. (D) Participants with AN/BDD scored
significantly higher on the HAM-A scale than healthy controls (p< 0.001). (E) Participants with AN/BDD scored significantly higher on the
MADRS scale than healthy controls (p< 0.001). (F) The first single principal component (PC1) of HAM-A and MADRS explained 93% of the
variance among all participants with HAM-A and MADRS scores (n = 84). Larger markers represent the presence of more than one participant.
BABS = Brown Assessment of Beliefs Scale; HAM-A = Hamilton Anxiety Rating Scale; MADRS = Montgomery-Asberg Depression Scale.
https://doi.org/10.1371/journal.pone.0213974.g001
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higher NPL (lower globally efficient white matter connectivity) with AN (log odds 6.0 per unit,
SE 2.9, p^ = 0.02), a positive association of higher BABS scores (lower insight) with BDD (log
odds -0.07 per unit, SE 0.07, p^ = 0.011 with a non-Gaussian distribution), and no significant
association of MH with either group (-0.63 per unit, SE 0.75, p^ = 0.40) (Fig 2D).
Multistep prediction
The two-step combination of the above models had a three-group leave-one-out accuracy of
76% (64/84, 95% CI: 67–85%, permutation mean 35%, p^ < 10  4) with AN predictive value of
63% (12/19, permutation mean 40%, p^ < 0:001), BDD predictive value of 76% (25/33, permu-
tation mean 41%, p^ < 0:001), and healthy control predictive value of 84% (27/32, permutation
mean 33%, p^ < 0:001).
Fig 2. Classifier performance. (A) The receiver operator characteristic of the healthy controls (denoted as CTL) vs AN/BDD model. Our model
distinguished healthy controls from participants with AN or BDD with an AUC-ROC of 93%. (B) Bars reflect the weight of each factor used in the
CTL vs AN/BDD classification, expressed as the odds ratio per standard deviation. Error bars are SEM and asterisks demarcate statistically
significant features (p^^< 0:05). (C) Our AN vs BDD model distinguished participants with AN from those with BDD with an AUC-ROC of 67%.
(D) The weight of each factor used in the AN vs BDD classification, expressed as an odds ratio per standard deviation. Error bars are (Gaussian)
SEM and thus for reference only; significance values were calculated from the (non-Gaussian) permutations.
https://doi.org/10.1371/journal.pone.0213974.g002
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Discussion
By combining multimodal neuroimaging and psychometric data, we were able to differentiate
accurately between healthy controls, participants with weight-restored AN, and participants
with BDD. This represents the first study to apply this approach to AN and BDD for classifica-
tion purposes and to understand relative contributions of factors for distinguishing these
DSM-defined syndromes. These results shed light on a more dimensional understanding of
the neurobiological and psychometric variables that contribute to these disorders.
Classification performance
While anxiety and depression scores were sufficient to distinguish healthy controls from those
with AN/BDD, a combination of psychometric and neuroimaging data best distinguished
individuals with weight-restored AN from those BDD. Yet, even with more predictive features,
our model distinguishing weight-restored AN from BDD was less accurate than our model dis-
tinguishing AN/BDD from healthy controls. As observed clinically, AN and BDD show
phenomenological overlap; thus, it is not surprising that differentiating healthy controls from
participants with either disorder was much more accurate than distinguishing participants
with weight-restored AN from those with BDD. Even though we excluded participants with a
DSM diagnosis of both conditions, our lower classification accuracy between weight-restored
AN and BDD, as compared to AN/BDD and healthy controls, supports previous findings that
some individuals with AN may share symptomatic and behavioral elements of BDD, and vice
versa [26–28]. The predictive power our model achieved in distinguishing two phenomenolog-
ically overlapping disorders highlights the utility of integrating functional and structural
neurobiological data with clinical symptoms and behavior-based data.
Our two-way classification accuracies—89% in distinguishing controls from individuals
with AN/BDD, and 74% in differentiating weight-restored AN from BDD—are similar to pre-
vious works in other disorders. Using neuroimaging data, other groups have distinguished
healthy controls from individuals with social anxiety disorder [53], ADHD [54], major depres-
sive disorder [55], autism [56], and Alzheimer’s disease [57] with an accuracy of 80–90%.
Fewer groups, however, have attempted to separate individuals with related but distinct diag-
noses. The closest comparable studies classified disorder subtypes or predicted the progression
of a disorder. For example, functional connectivity distinguished subtypes of ADHD with 65%
accuracy [54], regional white matter volume discriminated between treatment-resistant and
treatment-sensitive depression with an accuracy of 66% [55], and fMRI and PET data from
individuals with mild cognitive impairment predicted who would develop Alzheimer’s disease
within 18 months and who would not with 68% accuracy [57].
Combining both classification models yields a two-step clinical diagnostic flowchart for a
potential patient: (1) Does this individual potentially have an appearance-related psychiatric
disorder? (2) If so, how strongly does the evidence suggest that the individual has symptoms of
AN or BDD? By combining our participants’ results for both models, the relationship among
these conditions is more clear (Fig 3).
There was fairly strong separability between groups. Although the classifier confused
some healthy controls and participants with weight-restored AN, none of the participants with
BDD were misclassified as healthy controls. This suggests that if the two-stage classifier were
to classify an individual as likely having AN/BDD, and then were to assign a final prediction of
BDD, there would be a high likelihood that the individual has an actual clinical diagnosis of
BDD.
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Neurobiological interpretations
In our model, lower insight contributed significantly to the distinction between BDD and AN.
This accords with a previous study that found that, on average, individuals with BDD have
lower insight than individuals with AN [4]. Clinical experience also suggests that in AN, more
frequently than in BDD, a greater proportion of individuals possess the insight that their body
weight is low, yet they nevertheless desire to remain in an underweight state or achieve an
even lower weight, accounting for many recalcitrant cases [58,59]. Individuals with AN have
compulsive regimens of exercise, food restriction, or selectivity that remain ego-syntonic.
The result that the white matter network connectivity measure (NPL) contributed signifi-
cantly to the distinction between AN and BDD is in line with our previous finding of higher
Fig 3. Joint predictions of both models. The synthesis of the control (CTL) vs AN/BDD model and the AN vs BDD model reveals
a relatively clear delineation between healthy control participants (black), participants with AN (red), and participants with BDD
(blue).
https://doi.org/10.1371/journal.pone.0213974.g003
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NPL in AN than in BDD [3]. Our related previous research, however, was univariate, single-
modal, and contained no predictive modeling. In other words, whereas our previous univari-
ate analyses could distinguish significant differences among AN, BDD, and healthy controls
for each of the neuroimaging and psychometric data separately, the current results provide
information about how each measure contributes to differentiating the disorders when
accounting for the effects of the others. In the multimodal approach we developed here, insight
and NPL both contributed significantly to distinguishing AN from BDD in a multivariate con-
text, prompting the question of how these features might interact with each other to contribute
to brain-behavior relationships.
Indeed, the phenomenon of poor insight may itself be linked to NPL in AN. In prior work,
we found that poor insight in AN was associated with longer NPL in the anterior and posterior
cingulate cortices [3]. Because this finding was specific to these cingulate subregions, it seems
to support a relationship between insight and information transfer between these regions
(involved in error-detection and conflict monitoring [60]) and the rest of the brain, rather
than global network integration. Future studies are warranted to uncover potential relation-
ships between insight and regional or global brain network topology. This will help clarify
underlying connectivity patterns associated with the phenomenon of insight, which has
important clinical implications for if, and how, patients engage in treatment.
Interestingly, NPL in the AN group demonstrated properties of a bimodal distribution; one
subgroup had a clustering of NPL values that resembled those of the BDD and healthy control
cohorts, while another subgroup showed much longer NPL values. Thus, longer average NPL,
which suggests a less globally-integrated white matter connectivity network across the brain,
may be a useful distinguishing feature that separates AN from BDD. The differing network
topology of a subgroup of AN raises the question of whether classification methods alternative
to DSM might better capture natural “cut-points” of the neuropathology of AN. This was out-
side of the focus and scope of the present work, and future studies are required to investigate
this further.
Our results show that healthy controls could be differentiated easily from individuals with
appearance-related psychiatric disorders using a single psychometric metric of anxiety/depres-
sion. While this is informative, it illustrates that differentiating healthy controls from weight-
restored AN or BDD can be ascertained readily by a clinical assessment; neurobiological data
from neuroimaging is unnecessary. The more difficult distinction, in some clinical cases, is
between AN and BDD; our model also performed well with this classification.
Limitations and future directions
In this study, we based classification accuracy results on DSM criteria, though we acknowledge
the ongoing debate about the utility of DSM or International Classification of Diseases (ICD)
versus dimensional approaches, as suggested by the NIH Research Domain Criteria (RDoC),
in the classification of psychiatric disorders. The benefit of developing more advanced algo-
rithms for classification is predicated on the existence of at least some applications for diagnos-
tic classification. Despite limitations of DSM- or ICD-defined diagnostic categories, there is
practical value in distinguishing the clinical syndromes of AN from BDD, namely, for the sake
of clinical decisions about specific pharmacotherapy and psychotherapy approaches. As out-
lined above, these are notably different for the diagnostic categories of AN and BDD, and—
amongst other important implications of these distinctions—early interventions to prevent the
starvation state are imperative for the prevention of medical morbidity and mortality.
On an individual level, our statistical classification approach yielded different results from
the gold-standard (clinical diagnoses) in several cases. While this may reflect a limitation of
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the present method, it could also indicate different interpretations of clinical criteria when
applied to specific patients. With a modest sample of the present size, it would not likely be
informative to evaluate the classification differences on individuals, but future work may want
to consider whether such differences arise from factors that may ultimately prove useful in
interventions. There also may be yet-unidentified methodological and clinical variables that
moderate our classifier’s performance.
Our classification model was developed with information from participants from the local
community. Variations in methods of test administration, neuroimaging, clinical diagnostics,
and underlying heterogeneity of these disorders may differ slightly from location to location,
so these results need to be further validated on larger, independent datasets from different
regions that capture the full range of the disease before direct application to clinical medicine.
Prior to any considerations of applying this method in clinical diagnostics, several addi-
tional follow up studies are needed to 1) replicate the findings in independent and larger sam-
ples, and 2) test and validate the approach in populations for whom this tool would be most
useful clinically. These populations include the following: 1) those with early stages of illness,
namely, adolescents who have not yet experienced significant weight loss and stand to benefit
from targeted interventions that could prevent the most impactful manifestations of the illness;
2) those at risk of developing either disorder, perhaps because of a strong family history and/or
anxious temperament in childhood; and 3) those who fall on the border between AN and
BDD, as exemplified in the Introduction.
Additional testing and validation in acute, rather than weight-restored, AN populations is
necessary to understand its generalizability. A strong caveat of the current dataset, therefore, is
that the informative neurobiological feature of NPL, and conceivably even insight, may have
been influenced by previous starvation states in AN participants. It is necessary to determine
the utility of this classification procedure using the current features through future validation,
which can be accomplished through the longitudinal study of individuals at risk or in very
early pre-starvation stages of symptom manifestation. Similarly, testing in normative adoles-
cent populations is also necessary given the more nuanced differences in appearance concerns
and behaviors between healthy adolescents and individuals who meet specific clinical criteria.
Additionally, given the increased likelihood of acquisition heterogeneity in multimodal data,
these results must be tested for generalizability across worldwide research centers.
If validated successfully, our multimodal, two-stage classification model may aid in clinical
disambiguation between healthy individuals and individuals with AN or BDD. Critically, if the
methodology proves accurate in populations that are at risk or very early in the course of ill-
ness, then it may contribute to the prevention of the starvation state. This step not only would
help reduce the risk of medical morbidity and mortality, but also could improve the effective-
ness of other treatments that have difficulty taking hold in the context of extreme malnutrition
[61,62].
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